11
Sep
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies
Top Stories Tamfitronics HONG KONG, Sept 11, 2024 - (ACN Newswire) - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmac...
You must be 18 years of age or older to view page. Please verify your age to enter.
Your access is restricted because of your age.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.